Skip to main content
Top
Published in: Annals of Surgical Oncology 10/2008

01-10-2008 | Melanomas

Slow Dynamics of Lymphoscintigraphic Mapping Is Associated to the Negativity of the Sentinel Node in Melanoma Patients

Authors: Laurence Mahieu-Renard, MD, Serge Cammilleri, MD, Roch Giorgi, MD, PhD, Caroline Gaudy-Marqueste, MD, Olivier Mundler, MD, Marie-Aleth Richard, MD, Jean-Jacques Grob, MD

Published in: Annals of Surgical Oncology | Issue 10/2008

Login to get access

Abstract

Aims

To confirm an association between a slow kinetics in the lymphoscintigraphic mapping of the sentinel node (SN), and SN negativity (SN−) in melanoma (MM) patients, and to test whether a long scintigraphic appearance time (SAT) could be a noninvasive surrogate marker of SN−.

Methods

A retrospective cohort of 194 successive MMs with Breslow ≥1.5 mm with follow-up >18 months after SN procedure were retrospectively randomized into two groups: a test sample (T) (two-thirds) to assess the relationship between SN status and lymphoscintigraphy dynamics, and to identify a potential scintigraphic marker of SN−, which was confirmed in the validation sample (V) (one-third). A prospective cohort of 150 consecutive new patients was then used to test the negative predictive value (NPV) of this marker.

Results

In sample T, SAT was significantly lower in SN+ than SN− patients (p = 0.04). In a multivariate model, SAT was predictive of SN status, before tumor thickness. SAT was also predictive of disease of disease-free survival (DFS) and overall survival (OS). None of the patients with SAT >30 min (24.8%) were SN+. SAT >30 min was validated as a potential marker for SN− in sample V with NPV = 100% (confidence interval [CI] 84.6−100). In the prospective cohort, the NPV of this marker was however only 84.6% (CI 65.1–95.6).

Conclusion

Slow SAT is associated with SN− and better survival, which opens interesting hypotheses as to the process of the first nodal metastasis. However, the best possible lymphoscintigraphic marker was not consistent enough to recognize patients in whom the invasive phase of SN biopsy could be avoided.
Literature
1.
go back to reference Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-Institutional Melanoma Lymphatic Mapping Experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol march1999;17:976–83 Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-Institutional Melanoma Lymphatic Mapping Experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol march1999;17:976–83
2.
go back to reference Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol2001;19:3622–34PubMed Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol2001;19:3622–34PubMed
3.
go back to reference Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer2001; 91:2401–8PubMedCrossRef Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer2001; 91:2401–8PubMedCrossRef
4.
go back to reference Morton DL, Thompson JF, Cochran AJ, et al. MSLT Group: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med2006;355:1307–17PubMedCrossRef Morton DL, Thompson JF, Cochran AJ, et al. MSLT Group: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med2006;355:1307–17PubMedCrossRef
5.
go back to reference Testori A, Lazzaro G, Baldini F, et al. The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients. Melanoma Res2005;15:191–8PubMedCrossRef Testori A, Lazzaro G, Baldini F, et al. The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients. Melanoma Res2005;15:191–8PubMedCrossRef
6.
go back to reference Belhocine T, Pierard G, De Labrassinne M, et al. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection. Oncologist2002;7:271–8PubMedCrossRef Belhocine T, Pierard G, De Labrassinne M, et al. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection. Oncologist2002;7:271–8PubMedCrossRef
7.
go back to reference Maza S, Valencia R, Geworski L, et al. Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study. Eur J Nucl Med Mol Imaging2003;30:538–44PubMed Maza S, Valencia R, Geworski L, et al. Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study. Eur J Nucl Med Mol Imaging2003;30:538–44PubMed
8.
go back to reference Mariani G, Gipponi M, Moresco L, et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med2002;43:811–27PubMed Mariani G, Gipponi M, Moresco L, et al. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma. J Nucl Med2002;43:811–27PubMed
9.
go back to reference Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med2003;44:570–82PubMed Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med2003;44:570–82PubMed
10.
go back to reference Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol1998;16:2253–60PubMed Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol1998;16:2253–60PubMed
11.
12.
go back to reference Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg1992;127:392–9PubMed Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg1992;127:392–9PubMed
13.
go back to reference Balch CM, Houghton AN, Sober AJ, et al. Cutaneous melanoma, 3rd edition. Quality Medical, St. Louis, MO, 1998:494–6 Balch CM, Houghton AN, Sober AJ, et al. Cutaneous melanoma, 3rd edition. Quality Medical, St. Louis, MO, 1998:494–6
14.
go back to reference Shields JD, Borsetti M, Rigby H, et al. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer2004;90:693–700PubMedCrossRef Shields JD, Borsetti M, Rigby H, et al. Lymphatic density and metastatic spread in human malignant melanoma. Br J Cancer2004;90:693–700PubMedCrossRef
15.
go back to reference Rossi CR, Mocellin S, Scagnet B, et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol2003;83:80–4PubMedCrossRef Rossi CR, Mocellin S, Scagnet B, et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J Surg Oncol2003;83:80–4PubMedCrossRef
16.
go back to reference Hocevar M, Bracko M, Pogacnik A, et al. The role of preoperative ultrasonography in reducing the number of sentinel lymph node procedures in melanoma. Melanoma Res2004;14:533–6PubMedCrossRef Hocevar M, Bracko M, Pogacnik A, et al. The role of preoperative ultrasonography in reducing the number of sentinel lymph node procedures in melanoma. Melanoma Res2004;14:533–6PubMedCrossRef
17.
go back to reference Uren RF, Howman-Giles RB, Thompson JF, et al. Variability of cutaneous lymphatic flow rates in melanoma patients. Melanoma Res1998;8:279–82PubMedCrossRef Uren RF, Howman-Giles RB, Thompson JF, et al. Variability of cutaneous lymphatic flow rates in melanoma patients. Melanoma Res1998;8:279–82PubMedCrossRef
Metadata
Title
Slow Dynamics of Lymphoscintigraphic Mapping Is Associated to the Negativity of the Sentinel Node in Melanoma Patients
Authors
Laurence Mahieu-Renard, MD
Serge Cammilleri, MD
Roch Giorgi, MD, PhD
Caroline Gaudy-Marqueste, MD
Olivier Mundler, MD
Marie-Aleth Richard, MD
Jean-Jacques Grob, MD
Publication date
01-10-2008
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0080-2

Other articles of this Issue 10/2008

Annals of Surgical Oncology 10/2008 Go to the issue

Gastrointestinal Oncology

Sentinel Node Biopsy Without Scars